Lataa...
Solifenacin in Multiple Sclerosis Patients with Overactive Bladder: A Prospective Study
Objective. To assess the efficacy and the effect on Qol of solifenacin for the treatment of OAB in MS patients. Patients and Methods. Thirty MS patients suffering from OAB were treated with solifenacin 5/10 mg for 8 weeks. The first 4 weeks patients received solifenacin 5 mg. At week 4 patients coul...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hindawi Publishing Corporation
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3114086/ https://ncbi.nlm.nih.gov/pubmed/21687581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/834753 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|